20 August 2024
20 August 2024
Cyril Ramaphosa, the president of South Africa, has asked the WHO to ensure African countries have equitable access to mpox vaccines.
The partners will conduct a study using blood samples and joint biopsies from various patient subgroups, focusing on those resistant to current treatments.
TEPKINLY is the first subcutaneous T-cell engaging bispecific antibody approved for this indication in the EU, EEA and Northern Ireland..
Looking to potentially market their flagship drug SPI-1005, Sound CEO Jonathan Kil is keen to retain WuXi AppTec as a partner.
The research award will target Campylobacter, Shigella and Enterotoxigenic E coli strains.
The drug binds to cancer cells, internalising and then releasing a cytotoxic agent, leading to cell death.
PT217 has received orphan drug designations from the FDA for the treatment of neuroendocrine carcinoma, in addition to small cell lung cancer.
Colombia’s vulnerability to shortages and its dependence on other countries for supplies was exposed during the Covid-19 pandemic.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
